| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |